News & Press Releases

Mergermarket recently featured insights from Cheryl Reicin, Life Sciences Practice Co-chair, in an article discussing a potential 2026 rebound in M&A activity across the contract development and manufacturing organization (CDMO) sector, which provides outsourced development and manufacturing services to biopharma and medical‑device companies. 

PE Hub featured insights from Private Equity Practice Co-chair Matthew Simpson in an article that discusses the impact of tariffs on dealmaking.

Mintz advised global investment firm Sixth Street in connection with its $500 million strategic financing facility with Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing.  

Mintz is pleased to welcome Tung-On (T.O.) Kong, who has joined the firm as a Member in its Intellectual Property Division. A nationally recognized life sciences patent strategist, T.O. brings more than two decades of trial and appellate experience representing pharmaceutical, biotechnology, medical device, and diagnostics companies in bet-the-company disputes.

Law360 Pulse featured the addition of Member T.O. Kong to Mintz's Intellectual Property Division in San Francisco.

Of Counsel Michelle Capezza was quoted in a Fiduciary News article about how plan sponsors must re-assess their governance process amidst rising ERISA lawsuits.